JASON EHRLICH - 11 Jun 2021 Form 4 Insider Report for Kodiak Sciences Inc. (KOD)

Role
Chief Medical Officer and Chief Development Officer
Signature
/s/ David Peinsipp, Attorney-in-Fact for Jason Ehrlich
Issuer symbol
KOD
Transactions as of
11 Jun 2021
Net transactions value
-$97,208
Form type
4
Filing time
15 Jun 2021, 19:06:52 UTC
Previous filing
24 May 2021
Next filing
17 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KOD Common Stock Options Exercise +2,900 +4.6% 66,115 11 Jun 2021 Direct F1, F2
transaction KOD Common Stock Sale $97,208 -1,147 -1.7% $84.75* 64,968 15 Jun 2021 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KOD Stock Option (Right to Buy) Award $0 +18,450 $0.000000 18,450 11 Jun 2021 Common Stock 18,450 $73.51 Direct F4
transaction KOD Restricted Stock Units Award $0 +11,600 $0.000000 11,600 11 Jun 2021 Common Stock 11,600 Direct F1, F4
transaction KOD Restricted Stock Units Options Exercise $0 -2,900 -25% $0.000000 8,700 11 Jun 2021 Common Stock 2,900 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock.
F2 Includes 54 shares acquired under the 2018 Employee Stock Purchase Plan on May 31, 2021.
F3 The sale was made to cover tax withholding obligations in connection with vesting and settlement of 1/4th of the Reporting Person's performance-based RSU granted on December 30, 2019.
F4 On December 30, 2019 the Reporting Person was awarded a performance-based award. 1/4th of the award vested on June 11, 2021 upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the award will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

Remarks:

Chief Medical Officer and Chief Development Officer